Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing ...

Bryan Johnson, a 47-year-old US software millionaire, had made waves with his ambitious mission to reverse ageing. Now, the anti-aging influencer has revealed that he has dumped longevity drug ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Rapamycin, an immunosuppressant commonly prescribed off-label because it has been shown to extend the healthy lifespan of mice, lacks FDA approval for anti-aging use. Despite this, some physicians ...

The former Silicon Valley executive said preclinical and clinical research indicated that prolonged rapamycin use can disrupt ...

The US Food and Drug Administration has not approved rapamycin for anti-aging therapy, but physicians have been prescribing it off-label because it has been shown to extend the healthy lifespan of ...

Bryan Johnson, the tech whiz turned anti-aging aficionado, shells out around $2 million a year trying to outsmart the Grim Reaper. However, his latest move has the internet rolling on the floor ...

Researchers have developed AI-driven evaluation standards to enhance ageing-related interventions, aiming to improve health ...